Advertisement
Video

What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: How can we help our patients avoid those risks?

08/07/2018

Related Content

Gastroenterology
Gastroenterology
Anita Afzali, MD, MPH, on Key Takeaways for Transitioning a Patient From Pediatric to Adult Care
08/06/2019
In this video, Anita Afzali, MD, MPH, highlights the key takeaways for specialists about transitioning a patient from pediatric to adult care.
08/06/2019
Gastroenterology
Gastroenterology
Mimics of IBD
08/01/2018
08/01/2018
Gastroenterology
Gastroenterology
New Therapies That Target the JAK-STAT Pathway and Other Small Molecules
08/08/2018
08/08/2018
Rheumatology
Rheumatology
Karen Onel, MD, on Why the New JIA Guideline Is Needed
01/06/2021
In this video, Karen Onel, MD, explains why the most recent JIA recommendations are needed as well as what new areas they address that had not been included in past guidelines.
01/06/2021
Gastroenterology
Gastroenterology
Positioning Immunomodulators as Monotherapies or in Combination with Biologics
08/01/2018
08/01/2018